Amedisys, Inc.
AMED
$94.50
$0.230.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -205.48% | -34.86% | 140.24% | -42.96% | -39.08% |
| Total Depreciation and Amortization | 8.06% | 6.45% | 2.36% | 2.71% | -0.81% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 256.11% | -57.52% | -89.82% | 4.74% | 77.37% |
| Change in Net Operating Assets | 102.95% | 202.72% | -153.14% | -96.39% | 194.87% |
| Cash from Operations | 16.52% | 1,173.09% | -13.91% | -125.20% | 47.52% |
| Capital Expenditure | 41.33% | -40.75% | 0.65% | -97.78% | -3.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.10% | -1,556.25% | 97.12% | -108.38% | -369.23% |
| Cash from Investing | 37.22% | -133.30% | 79.72% | -106.68% | -9.27% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -8.17% | -52.75% | 54.35% | 85.88% | 87.67% |
| Issuance of Common Stock | -- | -89.92% | -- | -- | -100.00% |
| Repurchase of Common Stock | 38.00% | 30.27% | -64.13% | 52.83% | -6,512.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 79.78% | -6,219.51% | 74.16% | 192.90% | -176.70% |
| Cash from Financing | 16.54% | -141.24% | -28.55% | 84.97% | 17.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.86% | 613.81% | -12.86% | -221.33% | 97.80% |